Fukushima et al. used an athymic mouse cancer xenograft model to investigate the effectiveness of near-infrared photoimmunotherapy with an anti-ICAM-1 antibody conjugated to IR700, a silica-phthalocyanine dye that, upon activation by near-infrared light, disrupts cancer cell membranes [271]. Here, ICAM1 is linked to cancer.